Ocera Therapeutics, Inc. Series C $35.5M

Posted in I - Series C, Q - 1Q08, R - WEST, X - GI

Ocera Therapeutics (San Diego, CA) a clinical stage company focused on gastrointestinal and liver diseases closed a $35.5M Series C financing. Participants include Montagu Newhall Associates, InterWest Partners, AgeChem Venture Fund, Cross Creek Capital, FinTech, CDIB BioScience, Domain Associates, Sofinnova Ventures and Thomas, McNerney & Partners.

Ranier Technology: Series C $15.8M

Posted in I - Series C, Q - 1Q08, R - INTERNATIONAL, X - Device (Spine)

Ranier Technology (United Kingdom) a development stage company focused on artificial spinal disc replacement closed a $15.8M Series C financing. Participants include Alliance Trust Equity Partners and First Ventures.

PEAK Surgical, Inc.: Series C $21M

Posted in I - Series C, Q - 1Q08, R - WEST, X - Device (Electrosurgery)

PEAK Surgical (Palo Alto, CA) an early-stage medical device company focused on pulsed plasma electrosurgery for cutting, coagulation and tissue welding closed a $21M Series C financing. Participants include Signet Healthcare Partners, Lehman Brothers and Venrock Associates.

BioVascular, Inc.: Series C $10.8M

Posted in I - Series C, Q - 1Q08, R - WEST, X - Cardiology

BioVascular (San Diego, CA) a development stage biotechnology company focused on novel cardiovascular therapeutics closed a $10.8M Series C financing. Participants include BB Biotech Ventures and Domain Associates.

Bridge Laboratories, Inc.: Series C $18M

Posted in I - Series C, Q - 1Q08, R - MID ATLANTIC, X - CRO

Bridge Labs (Gaithersburg, MD) a pre-clinical contract research organization closed a $18M Series C financing. Participants include Granite Global Ventures.

IonGate Biosciences, GmbH: Series C $6.7M

Posted in I - Series C, Q - 1Q08, R - INTERNATIONAL, X - Device (Diagnostic)

IonGate Bio (Germany) developer of drug screening and measurement devices closed a $6.7M Series C financing. Participants include Heidelberg Innovation and KfW.

Alder Biopharmaceuticals, Inc.: Series C $40M

Posted in I - Series C, Q - 1Q08, R - NORTH WEST, X - Antibody

Alder Biopharma (Bothell, WA) developer of unique antibody technologies that may increase antibody potency, accelerate production cycles, and lower production costs closed a $40M Series C financing. Participants include Delphi Ventures, TPG Biotech, Sevin Rosen Funds, Ventures West, H.I.G. Ventures, and WRF Capital.

Confirma, Inc.: Series C $17.5M

Posted in I - Series C, Q - 1Q08, R - NORTH WEST, X - Device (Imaging)

Confirma (Bellevue, WA) maker of MRI detection technology closed a $17.5M Series C. Participants include Telegraph Hill Partners, Fluke Venture Partners, Prism Ventureworks and Versant Ventures.

AgaMatrix, Inc.: Series C $23.7M

Posted in I - Series C, Q - 1Q08, R - NORTH EAST, X - Device (Diabetes)

AgaMatrix (Salem, NH) maker of blood glucose monitoring systems that provide results to help users better manage their diabetes closed a $23.7M Series C financing. Participants include Ferrer Freeman & Co.

AmpliMed Corp.: Series C $22.0M

Posted in I - Series C, Q - 1Q08, R - SOUTH WEST, X - Oncology

AmpliMed (Tucson, AZ) a clinical-stage pharmaceutical company with Phase II lead compounds for malignant melanoma and pancreatic cancer closed on $5M traunche of a $22M Series C financing. Participants include BioMed Venture Partners, Biotech Insight Ventures, Solstice Capital and Valley Ventures.

« Previous Entries

to top of page...